Q3 2025 Management View John Engel, Chairman, President & CEO, stated, "We delivered very strong results in the third quarter, and we again outperformed the market with our leading portfolio of ...
StockStory.org on MSN
5 Must-Read Analyst Questions From Integra LifeSciences’s Q3 Earnings Call
Integra LifeSciences’ third quarter was marked by operational disruptions and underwhelming revenue growth, resulting in a ...
StockStory.org on MSN
IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook
Detailed price information for Integra Lifesciences (IART-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback